This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2016-2026.
Company Filing History:
Years Active: 2016-2026
Title: Innovations of Yoshihisa Murata
Introduction
Yoshihisa Murata is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate Nrf2 and address various health conditions.
Latest Patents
Murata holds 3 patents, showcasing his innovative work. His latest patents include a nitrogen-containing heterocyclic compound that has the ability to activate Nrf2. This low-molecular compound or its salts and solvates are designed to enhance the activation of Nrf2, which plays a crucial role in cellular defense mechanisms. Another notable patent is for a dihydropyridazine-3,5-dione derivative, which serves as a pharmaceutical drug and a preventive agent for conditions such as hyperphosphatemia and chronic renal failure.
Career Highlights
Yoshihisa Murata is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company. His work has been instrumental in advancing therapeutic options for various diseases, reflecting his commitment to innovation in healthcare.
Collaborations
Murata has collaborated with notable colleagues, including Yoshihito Ohtake and Atsushi Kimbara, contributing to a dynamic research environment that fosters innovation.
Conclusion
Yoshihisa Murata's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to impact the development of new therapeutic agents.